A major pathophysiological consequence of hyperglycae mia is the extensive chemical interaction of glucose with proteins, leading to its attachment to these proteins with out the aid of enzymes. Even though the Maillard reac tions have been of considerable interest to food chemists since the tum of the century,' it has only been relatively recently that attention has focused on non-enzymic glyca tion of proteins in vivo. Although non-enzymic glycation leading to formation of reversible Amadori products acts on many proteins throughout the body, it is less obvious how these products are related to the pathophysiology of diabetic complications. Recent efforts have focused on biologically important further products of the glycation reaction, which are derived slowly from the Amadori product following a sequence of further reactions and rearrangements? These compounds, in contrast to the Amadori product, are formed irreversibly resulting in accumulation on long-lived proteins; these have been called advanced glycation end (AGE) products.
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BIOCHEMISTRY OF THE EARLY MAILLARD REACTION
The initial Maillard reaction is the condensation of the free aldehyde group of carbohydrate with either the f-amino group of lysine or hydroxylysine residues or the a-amino group of the N-terminal amino acid of proteins.2 Only open forms of sugars react with proteins, the carbonyl group of an acyclic monosaccharide attaching to a protein amino group via nucleophilic attack to form a labile aldi mine (Schiff base).2 This product may hydrolyse back to glucose and protein or undergo an Amadori rearrange ment to form a l-amino-I-deoxyfructose (fructosamine) derivative by a stable, though slightly reversible, keto amine linkage (Fig. 1 ). This product can cyclise to a ring structure (N-substituted-I-amino-deoxyketopyranose ). 2 The rate of the Amadori rearrangement is approximately one-sixtieth that of the dissociation to glucose and protein3 and also varies between proteins: for example, the Ama- dori rearrangement occurs about five times more rapidly in albumin than in haemoglobin. 4 The labile Schiff base form can also exist as a cyclic glucose adduct (N-substituted aldosylamine) and in vivo proteins will exist predom inantly in the cyclic form of both the Schiff base and the Amadori product, although the labile form is probably lost in most purification procedures. 4 Glycation of haemoglobin is somewhat atypical, as this reaction occurs predominantly between glucose and the N-terminal valine of the �-chain of haemoglobin to form HbA,/ on other proteins glucose adducts are found on lysine and hydroxylysine residues.2 A variety of other aldose and ketose sugars, including glucose-6-phosphate, galactose, mannose, ribose, fructose and xylulose, can participate in the glycation reaction.6 The relative reactiv ity varies up to 300-fold between monosaccharides and depends largely on the equilibrium between the reactive open (carbonyl) and closed (hemiacetal) configurations of the sugar. Aldose sugars react more rapidly than ketose sugars since the aldehyde carbonyl groups are relatively more electrophilic than those of the ketoses.6 Glucose is one of the least reactive of the aldose sugars, with only 0.001% existing in the acyclic form/ but quantitatively it is the major carbohydrate in humans and most glycated proteins are glucose adducts.
Circulating short-lived proteins (e.g. albumin, apopro- can be glycated, which is of potential relevance given the increased incidence of atherosclerosis and thromboem bolic events in diabetes. Fibrinogen23 and platelet pro teins, especially myosin and glycoproteins lIb and IIIa,24,25 undergo glycation despite their short plasma half-lives, but disturbances of platelet--collagen interac tions as a consequence of glycation have not been demonstrated. 26 However, glycation of heparin co-factor II, a protease inhibitor responsible for thrombin inhibi tion, results in a decreased affinity of the inhibitor for thrombin.27 Glycation of proteins involved in lipid metabolism has been proposed as a mechanism precipitating the increased incidence of atherosclerotic vascular disease in diabetes mellitus. Glycation of very low density lipoprotein (VLDL) impairs metabolism of its associated triglyceride and delays clearance of the particle as a whole. 28 Glycation of high density lipoproteins of subclass 3 reduces their ability to remove cholesterol from extrahepatic cells and may be associated with decreased reverse transport.29 Gly cated low density lipoproteins (LDL) are cleared at a slower rate than native LDL by the LDL receptor in non diabetic animals,30 but levels of glycated apolipoprotein B, the structural apoprotein of LDL, are not altered in dia betics, possibly due to an increased clearance of glycated LDL by the non-receptor-mediated scavenger macro phage pathway.31
BIOCHEMISTRY OF THE LATE MAILLARD REACTION
The formation of the Amadori product discussed above is considered the first step in the Maillard or browning reac tion, which was first observed in 19121 when it was noted that amino acids heated in the presence of reducing sugars develop a yellow-brown colour. The Amadori product can undergo a further series of dehydration and rearrangement reactions. Their identification is difficult due to both the complexity and the heterogeneity of their presumed structure. Pongor et al. 33 were the first to propose a specific structure for an AGE product, suggesting a heterocyclic imidazole deriva tive, 2-(2-furoyl)-4(5)-(2-furanyl)-lH-imidazole (FFI), is generated via a condensation reaction of two Amadori products (Fig. 2 ). An antibody has been raised to a deriva tive of FFI bound to bovine serum albumin (BSA) and used in a radioimmunoassay to demonstrate the presence of FFI in albumin and globulin fractions of normal serum,34 suggesting the formation of FFI in vivo. How ever, Njoroge et al. 35 A second protein cross-link, having spectral character istics similar to those of AGE products, was first isolated from insoluble dura mater collagen. 37 It has since been demonstrated to consist of lysine and arginine cross linked through a ribose and has been named pentosidine38 (Fig. 2) . Tissue pentosidine levels have been shown to increase with age and to be elevated in patients with end stage renal disease.39 Doubt should be cast on the assertion that levels are raised in patients with diabetes, given that only two subjects with 'true' type I (insulin-dependent) diabetes were studied and their renal function was not documented.39 Given this, and the fact that only pentose and not hexose sugars participate in the reaction,38 the relationship of pentosidine to the complications of diabetes seems uncertain. This may, in part, explain the W. G. JOHN AND E. J. LAMB failure to observe a decrease in skin collagen pentosidine following institution of improved glycaemic control in diabetics. 40 Alternatively, Baynes41 has suggested that pentosidine is the result of an oxidative reaction between lysine and arginine. In addition to these AGE products, two further pyrrole-related compounds have been described and structures proposed. These are l-alkyl-2-formyl-3,4-diglycosylpyrrole (AFGP)42 and pyrraline (5-hydroxymethyl-l-neopentylpyrrole-2-carbaldehyde )32 (Fig. 2) .
AUTOXIDATIVE GLYCATION AND GLYCOXIDATION
There is recent evidence to suggest that protein glycation may not be the only mechanism by which proteins are modified by glucose. Glucose may act as a catalyst of chemical modification of proteins (autoxidative glyca tion) following a transition-metal-catalysed oxidation to form deoxyglucosones. These are more reactive than the parent monosaccharide and can react with proteins to form ketoimine adducts which can initiate further Mail lard reactions. The reaction occurs following enolisation with generation of free radicals and hydrogen peroxide (glucose autoxidation), which could damage neighbour ing molecules causing protein fragmentation and lipid oxidation. 43 The changes which result from in vitro incu bation of protein in a glucose medium, such as fluoro phore formation and conformational changes, can be inhibited using chelating agents which trap transition metals or free-radical scavengers, suggesting that oxida tive reactions may be involved in glucose-induced pro tein modification in the absence of glycation.43 Ascorbic acid and arachidonic acids were also found to be capable of fluorophore generation in bovine lens cry stall ins and BSA respectively as a result of metal-catalysed oxidation reactions, suggesting that the reaction of glucose with protein may not be the sole cause of protein modifica tion.44 Changes in vitro currently attributed to glycation could equally be accounted for by autoxidative glycation and may depend upon the presence of trace amounts of transition metals present in most physiological buffers. 43 However, specific products of autoxidative glycation, such as ketoimines, have not been identified in vivo or in vitro. 41 Ketoamines have been shown to undergo autoxidation with generation of the superoxide anion. 45, 46 It has recently been demonstrated that glycation of erythrocyte CU,Zn superoxide dismutase inhibits its free-radical scavenging activity.47 Thus glycation may amplify the effects of free radical-induced damage.
Oxidation consequent upon glycation may also be involved in protein modification (glycoxidation). Oxida tive cleavage of the Amadori product fructose-lysine yields carboxymethyUysine (CML) and erythronic acid,48 and fructose-hydroxylysine (found only in collagen) yields carboxymethylhydroxylysine (CMhL). These com pounds are formed in reactions where the oxidant is a reac tive form of oxygen, and therefore formation is inhibited by anaerobic conditions, metal ion chelators and oxygen radical scavengers.41 They have been found at increased concentration in· urine49 and collagen from diabetics, suggesting an underlying increase in oxidative damage to proteins in this disease.41 Alternatively, formation of CML and CMhL may represent a breakdown pathway limiting the 1}Il1ount of Amadori product available for AGE product formation. 48 There is still a significant debate as to the precise relationship and relative importance of the Maillard and oxidative reactions. It has been suggested that glycation may enhance a protein's potential exposure to oxidative damage and increase its ability to participate in free radical-mediated reactions.50 Much of the increase in pro tein-related fluorescence currently attributed to AGE product formation by glycation may be a consequence of oxidative reactions. 41 Indeed it has been shown51 that the use of captopril, a known free-radical scavenger,52 and other thiol-containing compounds, can inhibit fluores cence formation in proteins exposed to glucose. Presented in Fig. 3 is a hypothetical sequence of events linking glu cose and free-radical-mediated modification of proteins.
MODIFICATION OF STRUCTURAL PROTEINS
A variety of structural proteins have been shown to undergo glycation (Table I) . Given the long half-life of structural proteins considerable interest has centred on their ability to form AGE products. Attempts to link this to the complications of diabetes have met with mixed success. Lens a-, �-and y-crystallins can be glycated both in vivo and in vitro.53•54 Glycation of aldose reductase has been demonstrated to increase activity of this enzyme. 55 Epidermal tissue proteins which are glycated include abdominal skin,56 hair57 and nai1.58 Increased glycation of diabetic peripheral59 and central nervous system60 proteins has been demonstrated.
Given its importance as the most abundant structural 233 protein in the body and its ubiquitous presence in tissues associated with chronic diabetic complications, the pro tein which has received the most attention is collagen.
Collagen from a variety of sources has been shown to be glycated, including glomerular and lens capsule basement membranes,61 insoluble diaphragmatic tendons,62 skin63 and abdominal aorta.64 Glycation occurs predominantly on lysine but also on hydroxylysine residues, and the pres ence of glycosidically linked carbohydrate to hydroxyly sine residues does not affect their susceptibility to glycation. 65 In both ageing and diabetes collagen becomes more insoluble and more resistant to digestion, while such physical properties as mechanical strength are altered.66 Attempts have been made to relate these changes to glyca tion. Diabetes62.63.67-{ )9 and ageing62.63 have been shown to be associated with an increase in collagen glycation, although recent studies65 have failed to confirm the relationship with age. This difference is due to differing specificities of the method used. Early studies used the thiobarbituric acid assay which, in addition to glycated residues, may also react with glycosidically bound car bohydrate70 and oxidatively damaged proteins.71 This is particularly relevant to studies of collagen glycation, since O-glycosylated hydroxylysine residues are more than a hundred times more common than glycated hydroxylysine residues. 65 Glycation of collagen has been associated with a variety of alterations in function including impaired fibrillogen esis,72.73 eliciting an antibody response directed specific ally against glucitollysine residues/4 and reduced heparin binding.75 Amadori product formation on collagen has not, however, been shown to be related to any of the chronic complications of diabetes. 69 Given its slow turnover rate, most interest in the relationship of collagen glycation to diabetic complica tions has centred on its potential to participate in advanced glycation reactions and protein-protein cross-linking. Glycation of soluble calf skin collagen increased its bind ing to albumin and IgG, which could then function as planted antigens or antibodies in the formation in situ of immune complexes. 76 The formation of fluorescent, pig mented putative AGE products was found to increase with age and diabetes in dura mater77 and skin collagen,78 and to contribute to the increased stability to urea of rat tail ten don collagen.79 Collagen-linked fluorescence has been shown to be related to severity of some of the chronic com plications of diabetes.78 However, the determination of collagen-linked fluor escence is an indirect measure of AGE products and it has been suggested that these products may not be derived exclusively, or even predominantly, from the Maillard reaction.43 -46.5o For example, pentosidine corre lates strongly with collagen-linked fluorescence4o yet its relationship to the Maillard reaction products is uncer tain. The modifications of collagen which have been observed with both ageing and diabetes are most prob ably the result of a combination of glycative, oxidative and enzymically-mediated cross-linking events. The inter-relationship between these events, and possibly other post-translational modifications, and their rel evance to pathogenesis remain poorly understood.66 Col lagen-linked fluorescence is probably an index of damage from a variety of causes.
DISCUSSION
Early Maillard reaction products have been shown to be universally increased in diabetes but, generally, with few demonstrable pathological consequences. Indirect measurement of AGE products by protein-linked fluores cence, and direct measurement by a recently described radioreceptor assay,80-82 suggest that levels of AGE prod ucts are also elevated in diabetes.
What are the unifying features of the chronic complica tions of diabetes, and how may AGE products contribute to these processes? Diabetic micro-and macrovascular disease is characterised by accumulation of periodic acid Schitl (PAS) positive deposits of extravasated plasma pro teins, matrix expansion and cellular proliferation of the vessel wall, with consequent luminal narrowing.s3 There may also be activated complement membrane attack com plex deposits and discontinuous granular immunoglobulin deposit formation. 84 The Maillard reaction may contribute to these processes by promoting cross-linking of circulating proteins to matrix components and cross-linking of matrix compon ents to each other, and by altering cell-matrix interactions. The progressive occlusion of diabetic vessels is associated with binding of circulating proteins by AGE products on matrix proteins.s5 Once immobilised these proteins may themselves serve as additional substrate for AGE product formation and act as implanted antigens capable of in situ immune complex formation.76 AGE products of matrix proteins may cross-link to each other, further contributing to thickening and decreased elasticity of vessel walls.86 Impairment of basement membrane assembly73 and decreased binding of anionic proteoglycans75 following AGE product formation may contribute to the increased W. G. JOHN AND E. J. LAMB vascular permeability associated with diabetes.85 Decreased susceptibility of cross-linked matrix proteins to proteases may cause abnormal turnover of vessel wall constituents.x6 Normal modulation of the structural pro tein environment by macrophages and endothelial cells is also altered as a result of AGE product formation.84.s5 Additionally, matrix accumulation of AGE products quenches nitric oxide activity, resulting in vasodilatory impairment. 87 Given the pathological potential of Maillard reaction products, inhibitors of these reactions have been sought. The most interesting of these is the nucleophilic hydra zine compound, aminoguanidine. In vitro, the develop ment of fluorescence in BSA 88 and the impaired binding of heparin by collagen following exposure to glucose89 can be inhibited by aminoguanidine. In animal studies, aminoguanidine ameliorates the development of diabetes-associated changes as diverse as retinopathy,90 fluoroscopic and biophysical changes in collagen88. 91 -93 and increased urinary albumin excretion,92 and mal4 or may not92 inhibit glomerular basement membrane thickening.
The mechanism of action of amino guanidine is uncer tain (Fig. 4) : Khatami et al. 9 ) have suggested that its major action is to inhibit the formation of Amadori product by competing with protein for free open-chain glucose. Brownlee et al.s8 suggest that aminoguanidine acts by blocking reactive carbonyl groups on the ketoamine, hence preventing cross-link formation; the nucleophilic hydrazine group of amino guanidine attacks the electron deficient carbonyl carbon to form a hydrazone-type com pound. Although there is evidence for this reaction96 its importance is uncertain since the majority of the Amadori product exists in the cyclic form, and so has no carbonyl group.4 Dicarbonyl compounds have two such carbonyl groups, however, and aminoguanidine may trap these intermediate compounds. 96 Alternatively, it may inhibit fluorescence generation derived from lipid peroxidation products. 97 The most obvious feature of the diabetic state is the pre vailing hyperglycaemia. The Maillard reaction is attrac tive in providing a potential link between this fact and the histological and clinical features of diabetic complica tions; many remain convinced that a causal relationship exists. However, the Maillard reaction is only one of sev eral mechanisms by which hyperglycaemia and complica tions may be linked. Others, such as the aldose reductase pathway,9X may be equally (or more) relevant, and may indeed interact with the Maillard pathway to produce the final clinical picture of the chronic complications associ ated with diabetes.
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